Healthcare meetings by Conference Series: The hotspot for physicians and medical professionals

Food and Healthcare Press Releases Wednesday December 27, 2017 18:47
LONDON and SINGAPORE--27 Dec--PRNewswire/InfoQuest
-OMICS Group 2018 conference schedule release

Conference Series with the noble cause of joining hands with the medical and healthcare associations in their strive against health epidemics, to equip them with the necessary knowledge of novel trends in healthcare and to provide continuing education, organise medical and healthcare conferences across America, Europe and Asia with 1000+ scientific societies. Being one among the world's leading specialist in organising scientific and medical conferences, events trade, and consumer exhibitions both domestically and internationally in different verticals and horizontals like Medical, Pharma, Engineering, Science, Technology and Business, Conference Series attracts 50 million+ visitors, 25000+ unique visitors per conference and 75000+ page views for every individual conference would help in quantifying our presenters research and biography visibility to the online communities and get recognized worldwide.

Speaking on this occasion, Dr. Srinubabu Gedela , added, with the support from industry and academia OMICS Group and its subsidiaries able to schedule 3,000 global annual events in 40 countries for 2018. Healthcare conferences as significant events, which brings together a unique international mix of large and medium medical and clinical research and diagnostic companies, leading universities and medical research institutions. He called these conferences as a perfect platform to share experience, foster collaborations across industry and academia.

This year conference series annual meetings introducing new tracks for technology transfer, commercialization and marketing at all major annual meetings. New companies and budding entrepreneurs can deliver speech and exhibit their products and services to attract premium exposure of the industry's top buyers, vendors and investors.

Further   Dr. Srinubabu Gedela added, "Open access journals are all set to break the supremacy over the global information and scientific research in order to quell the knowledge gap. The successful and enormous growth of the organization in the past decade has been possible due to the collective contribution of the authors, editors, reviewers, and dedicated staff members."

About: OMICS International with its 3000+ employees has been a pioneer in the dissemination of scientific information on healthcare through open access. With the help of 50000+ well-qualified scientists as editorial board members   OMICS Group is able to grow from 10 journals in 2009 to 1000   peer reviewed journals by 2017 with an increased reader base of 50 million. OMICS International's ConferenceSeries.com hosts 3000+ global annual meetings .

Contact: 1-650-618-9867, ceo@omicsgroup.org, contact.omics@omicsonline.org
Logo - https://mma.prnewswire.com/media/431540/OMICS_International_Logo.jpg

Latest Press Release

Israel Ministry of Health Includes INSIGHTEC#s Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

INSIGHTEC(R), a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor...

The ImplantCenter Marks a New Era in the Hungarian Private Dental Service

The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education...

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after...

PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates

PharmaMar (MCE: PHM) has announced today the signing of an exclusive licensing agreement with Seattle Genetics Inc. (SGEN: NASDAQ GS) under which Seattle Genetics receives exclusive worldwide rights to certain PharmaMar proprietary molecules for the...

After multiple failed procedures at other medical institutions, Colorado man successfully treated for Atrial Fibrillation at Texas Cardiac Arrhythmia Institute at St. David#s Medical Center

"I was thinking I was on top of the world," Wiseman said. "I was keeping myself in shape. I was taking care of myself mentally and physically. My relationship was solid." Then, during a routine medical exam while serving in the military in California,...

Related Topics